{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:12:06Z","timestamp":1791234726409,"version":"4.1.0"},"reference-count":306,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100011033","name":"State Agency of Research","doi-asserted-by":"publisher","award":["HFpEF-DIVA PCI2024-153490"],"award-info":[{"award-number":["HFpEF-DIVA PCI2024-153490"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["848109"],"award-info":[{"award-number":["848109"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007793","name":"Kristian Gerhard Jebsen Foundation","doi-asserted-by":"publisher","award":["SKGJ-MED-024"],"award-info":[{"award-number":["SKGJ-MED-024"]}],"id":[{"id":"10.13039\/100007793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-1470\/SFB-1470-A07"],"award-info":[{"award-number":["SFB-1470\/SFB-1470-A07"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI21\/00946"],"award-info":[{"award-number":["PI21\/00946"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CB16\/11\/00483"],"award-info":[{"award-number":["CB16\/11\/00483"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Matrix Biology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.matbio.2024.08.008","type":"journal-article","created":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T22:05:40Z","timestamp":1724882740000},"page":"1-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact"],"prefix":"10.1016","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-6841","authenticated-orcid":false,"given":"Ida G.","family":"Lunde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2049-8577","authenticated-orcid":false,"given":"Karoline B.","family":"Rypdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7581-7870","authenticated-orcid":false,"given":"Sophie","family":"Van Linthout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Diez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-6528","authenticated-orcid":false,"given":"Arantxa","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.matbio.2024.08.008_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.831300","article-title":"Decellularization strategies for regenerating cardiac and skeletal muscle tissues","volume":"10","author":"Tan","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0002","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","article-title":"Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart","volume":"14","author":"Ott","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.matbio.2024.08.008_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001209","article-title":"Heart disease and stroke statistics: a report of us and global data from the American Heart Association","author":"Martin","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0004","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ejhf.1406","article-title":"Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology","volume":"21","author":"de Boer","year":"2019","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2024.08.008_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2020.11.006","article-title":"Progression of myocardial fibrosis in nonischemic DCM and association with mortality and heart failure outcomes","author":"Mandawat","year":"2021","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0007","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41569-020-00504-1","article-title":"Diffuse myocardial fibrosis: mechanisms, diagnosis and therapeutic approaches","volume":"18","author":"L\u00f3pez","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0008","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","article-title":"Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy","volume":"56","author":"O'Hanlon","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0009","doi-asserted-by":"crossref","first-page":"e760","DOI":"10.4244\/EIJ-D-23-01068","article-title":"Cardiac fibrosis as a predictor for sudden cardiac death after transcatheter aortic valve implantation","volume":"20","author":"Alnour","year":"2024","journal-title":"EuroIntervention"},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0010","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1253\/circj.CJ-11-0568","article-title":"Prognostic impact of myocardial interstitial fibrosis in non-ischemic heart failure","volume":"75","author":"Aoki","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.matbio.2024.08.008_bib0011","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijcard.2015.05.048","article-title":"Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction","volume":"191","author":"Kato","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0012","article-title":"Elevated myocardial extracellular volume fraction is associated with the development of conduction pathway defects following transcatheter aortic valve replacement","author":"Feroze","year":"2024","journal-title":"Catheter. Cardiovasc. Interv."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0013","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/cvr\/cvx146","article-title":"Fibroblasts and the extracellular matrix in right ventricular disease","volume":"113","author":"Frangogiannis","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2024.08.008_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.908663","article-title":"Viral myocarditis: classification, diagnosis, and clinical implications","volume":"9","author":"Sozzi","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tcm.2019.09.003","article-title":"Current understanding of fibrosis in genetic cardiomyopathies","volume":"30","author":"Eijgenraam","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0016","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1001\/jama.2013.1363","article-title":"Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy","volume":"309","author":"Gulati","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.matbio.2024.08.008_bib0017","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1161\/HYPERTENSIONAHA.122.19225","article-title":"Markers of focal and diffuse nonischemic myocardial fibrosis are associated with adverse cardiac remodeling and prognosis in patients with hypertension: the REMODEL study","volume":"79","author":"Iyer","year":"2022","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0018","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1093\/cvr\/cvab228","article-title":"Management of cardiac fibrosis is the largest unmet medical need in heart failure","volume":"118","author":"D\u00edez","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2024.08.008_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100528","article-title":"Ten years of extracellular matrix proteomics: accomplishments, challenges, and future perspectives","volume":"22","author":"Naba","year":"2023","journal-title":"Mol. Cell Proteomics."},{"key":"10.1016\/j.matbio.2024.08.008_bib0020","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/cvr\/cvw206","article-title":"Systems biology-opportunities and challenges: the application of proteomics to study the cardiovascular extracellular matrix","volume":"112","author":"Barallobre-Barreiro","year":"2016","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0021","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1021\/acs.jproteome.2c00526","article-title":"Mass spectrometry-based atlas of extracellular matrix proteins across 25 mouse organs","volume":"22","author":"McCabe","year":"2023","journal-title":"J. Proteome Res."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCRESAHA.120.317685","article-title":"Multiscale analysis of extracellular matrix remodeling in the failing heart","volume":"128","author":"Perestrelo","year":"2021","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.matbio.2024.08.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100528","article-title":"Ten years of extracellular matrix proteomics: accomplishments, challenges, and future perspectives","volume":"22","author":"Naba","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"issue":"D1","key":"10.1016\/j.matbio.2024.08.008_bib0024","doi-asserted-by":"crossref","first-page":"D1519","DOI":"10.1093\/nar\/gkac1009","article-title":"MatrisomeDB 2.0: 2023 updates to the ECM-protein knowledge database","volume":"51","author":"Shao","year":"2022","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.matbio.2024.08.008_bib0025","doi-asserted-by":"crossref","first-page":"e43882","DOI":"10.7554\/eLife.43882","article-title":"Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury","volume":"8","author":"Farbehi","year":"2019","journal-title":"Elife"},{"issue":"17","key":"10.1016\/j.matbio.2024.08.008_bib0026","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.jacc.2020.03.024","article-title":"Basic biology of extracellular matrix in the cardiovascular system, part 1\/4: JACC focus seminar","volume":"75","author":"del Monte-Nieto","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.matbio.2024.08.008_bib0027","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.jacc.2020.03.019","article-title":"Myocardial interstitial fibrosis in nonischemic heart disease, part 3\/4: JACC focus seminar","volume":"75","author":"D\u00edez","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0028","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCRESAHA.114.302533","article-title":"Myocardial extracellular matrix","volume":"114","author":"Rienks","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.matbio.2024.08.008_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114240","article-title":"Matrikines as mediators of tissue remodelling","volume":"185","author":"Jariwala","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0030","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/s41590-023-01551-9","article-title":"Immunology of human fibrosis","volume":"24","author":"Bhattacharya","year":"2023","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.matbio.2024.08.008_bib0031","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the TH1\/TH2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0032","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.yjmcc.2015.12.024","article-title":"The crossroads of inflammation, fibrosis, and arrhythmia following myocardial infarction","volume":"91","author":"Francis Stuart","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0033","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.123.21708","article-title":"Myocardial interstitial fibrosis in hypertensive heart disease: from mechanisms to clinical management","volume":"81","author":"Gonz\u00e1lez","year":"2024","journal-title":"Hypertension"},{"issue":"Suppl 2","key":"10.1016\/j.matbio.2024.08.008_bib0034","first-page":"S44","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"32","author":"Hamilton","year":"2009","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jacc.2004.09.053","article-title":"Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging","volume":"45","author":"Tandri","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0036","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacep.2017.03.002","article-title":"Molecular and cellular mechanisms of atrial fibrosis in atrial fibrillation","volume":"3","author":"Nattel","year":"2017","journal-title":"JACC Clin. Electrophysiol."},{"issue":"20","key":"10.1016\/j.matbio.2024.08.008_bib0037","article-title":"Mechanisms and implications of sex differences in cardiac aging","volume":"2","author":"Yusifov","year":"2022","journal-title":"J. Cardiovasc. Aging"},{"key":"10.1016\/j.matbio.2024.08.008_bib0038","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.3284","article-title":"Differences in presentation, diagnosis and management of heart failure in women. A scientific statement of the Heart Failure Association of the ESC","author":"Rosano","year":"2024","journal-title":"Eur. J. Heart Fail."},{"issue":"6603","key":"10.1016\/j.matbio.2024.08.008_bib0039","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1126\/science.abn3100","article-title":"Hematopoietic loss of Y chromosome leads to cardiac fibrosis and heart failure mortality","volume":"377","author":"Sano","year":"2022","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0040","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.119.045401","article-title":"Transcriptional and cellular diversity of the human heart","volume":"142","author":"Tucker","year":"2020","journal-title":"Circulation"},{"issue":"7838","key":"10.1016\/j.matbio.2024.08.008_bib0041","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvi\u0148ukov\u00e1","year":"2020","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.matbio.2024.08.008_bib0042","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.119.045115","article-title":"High-resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy","volume":"142","author":"McLellan","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0043","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/cvr\/cvae044","article-title":"Cardiac and perivascular myofibroblasts, matrifibrocytes, and immune fibrocytes in hypertension; commonalities and differences with other cardiovascular diseases","volume":"120","author":"Torimoto","year":"2024","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2024.08.008_bib0044","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1146\/annurev-physiol-021119-034527","article-title":"Cardiac fibroblast diversity","volume":"82","author":"Tallquist","year":"2020","journal-title":"Annu. Rev. Physiol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0045","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"6606","key":"10.1016\/j.matbio.2024.08.008_bib0046","doi-asserted-by":"crossref","first-page":"eabo1984","DOI":"10.1126\/science.abo1984","article-title":"Pathogenic variants damage cell composition and single cell transcription in cardiomyopathies","volume":"377","author":"Reichart","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.matbio.2024.08.008_bib0047","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.yjmcc.2016.01.010","article-title":"Fibroblast-myocyte coupling in the heart: potential relevance for therapeutic interventions","volume":"91","author":"Ongstad","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0048","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/0973-029X.185932","article-title":"Enigmatic insight into collagen","volume":"20","author":"Deshmukh","year":"2016","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0049","article-title":"Collagen biosynthesis, processing, and maturation in lung ageing","volume":"8","author":"Onursal","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0050","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00223-023-01171-3","article-title":"Is osteogenesis imperfecta associated with cardiovascular abnormalities? A systematic review of the literature","volume":"114","author":"Verdonk","year":"2024","journal-title":"Calcif. Tissue Int."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0051","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(84)90514-2","article-title":"Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death","volume":"38","author":"L\u00f6hler","year":"1984","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0052","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1073\/pnas.94.5.1852","article-title":"Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development","volume":"94","author":"Liu","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0053","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ajpath.2011.09.033","article-title":"A collagen \u03b12(I) mutation impairs healing after experimental myocardial infarction","volume":"180","author":"Hofmann","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"17","key":"10.1016\/j.matbio.2024.08.008_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/cells12172174","article-title":"Col1a2-deleted mice have defective type i collagen and secondary reactive cardiac fibrosis with altered hypertrophic dynamics","volume":"12","author":"Bowers","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0055","doi-asserted-by":"crossref","first-page":"H189","DOI":"10.1152\/ajpheart.00087.2018","article-title":"Elastin, arterial mechanics, and cardiovascular disease","volume":"315","author":"Cocciolone","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0056","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1161\/CIRCRESAHA.122.321123","article-title":"Tropoelastin improves post-infarct cardiac function","volume":"132","author":"Hume","year":"2023","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.matbio.2024.08.008_bib0057","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1242\/dev.119.4.1079","article-title":"Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin","volume":"119","author":"George","year":"1993","journal-title":"Development"},{"key":"10.1016\/j.matbio.2024.08.008_bib0058","doi-asserted-by":"crossref","unstructured":"H.W. Breisnes, A.H. Hansen, M.A. Karsdal, E.S. White, Chapter 31 - fibronectin, in: M.A. Karsdal (Ed.), Biochemistry of Collagens, Laminins and Elastin (Third Edition), Academic Press 2024, pp. 291-302.","DOI":"10.1016\/B978-0-443-15617-5.00008-1"},{"issue":"38","key":"10.1016\/j.matbio.2024.08.008_bib0059","doi-asserted-by":"crossref","first-page":"25879","DOI":"10.1074\/jbc.M109.024125","article-title":"Fibronectin binds and enhances the activity of bone morphogenetic protein 1","volume":"284","author":"Huang","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"40","key":"10.1016\/j.matbio.2024.08.008_bib0060","doi-asserted-by":"crossref","first-page":"37377","DOI":"10.1074\/jbc.M206286200","article-title":"Polymerization of type I and III collagens is dependent on fibronectin and enhanced by integrins alpha 11beta 1 and alpha 2beta 1","volume":"277","author":"Velling","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0061","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.201293","article-title":"The fibronectin ED-A domain enhances recruitment of latent TGF-\u03b2-binding protein-1 to the fibroblast matrix","volume":"131","author":"Klingberg","year":"2018","journal-title":"J. Cell Sci."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0062","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.118.034609","article-title":"Inhibiting fibronectin attenuates fibrosis and improves cardiac function in a model of heart failure","volume":"138","author":"Valiente-Alandi","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0063","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/cvr\/cvad078","article-title":"Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction","volume":"119","author":"Vistnes","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2024.08.008_bib0064","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.matbio.2018.01.001","article-title":"Sweet, yet underappreciated: proteoglycans and extracellular matrix remodeling in heart disease","volume":"75-76","author":"Christensen","year":"2019","journal-title":"Matrix. Biol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0065","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.matbio.2015.02.003","article-title":"Proteoglycan form and function: a comprehensive nomenclature of proteoglycans","volume":"42","author":"Iozzo","year":"2015","journal-title":"Matrix. Biol."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0066","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00441-016-2454-2","article-title":"Syndecans in heart fibrosis","volume":"365","author":"Lunde","year":"2016","journal-title":"Cell Tissue Res."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0067","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.111.056952","article-title":"Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia\/reperfusion injury","volume":"125","author":"Barallobre-Barreiro","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0068","article-title":"Proteomic analysis of the myocardium in hypertrophic obstructive cardiomyopathy","volume":"11","author":"Coats","year":"2018","journal-title":"Circulation: Genom. Precis. Med."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0069","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ehf2.14234","article-title":"Lumican accumulates with fibrillar collagen in fibrosis in hypertrophic cardiomyopathy","volume":"10","author":"Rixon","year":"2023","journal-title":"ESC Heart. Fail."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cvr\/cvv002","article-title":"Syndecan-4 is a key determinant of collagen cross-linking and passive myocardial stiffness in the pressure-overloaded heart","volume":"106","author":"Herum","year":"2015","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0071","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013518","article-title":"Syndecan-4 protects the heart from the profibrotic effects of thrombin-cleaved osteopontin","volume":"9","author":"Herum","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.matbio.2024.08.008_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbplus.2023.100135","article-title":"Temporal expression and spatial distribution of the proteoglycan versican during cardiac fibrosis development","volume":"19-20","author":"Sasi","year":"2023","journal-title":"Matrix. Biol. Plus."},{"issue":"13","key":"10.1016\/j.matbio.2024.08.008_bib0073","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.123.066298","article-title":"Versican promotes cardiomyocyte proliferation and cardiac repair","volume":"149","author":"Feng","year":"2024","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0074","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCULATIONAHA.119.045116","article-title":"Agrin promotes coordinated therapeutic processes leading to improved cardiac repair in pigs","volume":"142","author":"Baehr","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2024.08.008_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2014.07.005","article-title":"Revisiting the matricellular concept","volume":"37","author":"Murphy-Ullrich","year":"2014","journal-title":"Matrix. Biol."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0076","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ajhg.2015.04.021","article-title":"Recessive osteogenesis imperfecta caused by missense mutations in SPARC","volume":"96","author":"Mendoza-Londono","year":"2015","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0077","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.yjmcc.2009.06.018","article-title":"Cardiac extracellular matrix remodeling: fibrillar collagens and secreted protein acidic and rich in cysteine (SPARC)","volume":"48","author":"McCurdy","year":"2010","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0078","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.matbio.2017.12.009","article-title":"Thrombospondin-1 regulation of latent TGF-\u03b2 activation: a therapeutic target for fibrotic disease","volume":"68-69","author":"Murphy-Ullrich","year":"2018","journal-title":"Matrix. Biol."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0079","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1369\/0022155419851103","article-title":"Thrombospondin 1 and its diverse roles as a regulator of extracellular matrix in fibrotic disease","volume":"67","author":"Murphy-Ullrich","year":"2019","journal-title":"J. Histochem. Cytochem."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0080","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2353\/ajpath.2007.070056","article-title":"A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II","volume":"171","author":"Belmadani","year":"2007","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0081","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-017-0659-5","article-title":"Periostin in cardiovascular disease and development: a tale of two distinct roles","volume":"113","author":"Landry","year":"2017","journal-title":"Basic Res. Cardiol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0082","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jjcc.2013.09.013","article-title":"Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts","volume":"63","author":"Zhao","year":"2014","journal-title":"J. Cardiol."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0083","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCRESAHA.107.149047","article-title":"Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling","volume":"101","author":"Oka","year":"2007","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0084","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.matbio.2024.08.008_bib0085","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.jacc.2016.01.029","article-title":"Understanding the role of CCN matricellular proteins in myocardial fibrosis","volume":"67","author":"D\u00edez","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0086","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25116262","article-title":"Modified mRNA-mediated CCN5 gene transfer ameliorates cardiac dysfunction and fibrosis without adverse structural remodeling","volume":"25","author":"Song","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.matbio.2024.08.008_bib0087","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jacc.2016.01.030","article-title":"Matricellular protein CCN5 reverses established cardiac fibrosis","volume":"67","author":"Jeong","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0088","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1093\/hmg\/ddw090","article-title":"ERK1\/2 directly acts on CTGF\/CCN2 expression to mediate myocardial fibrosis in cardiomyopathy caused by mutations in the lamin A\/C gene","volume":"25","author":"Chatzifrangkeskou","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"Pt B","key":"10.1016\/j.matbio.2024.08.008_bib0089","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yjmcc.2015.11.003","article-title":"Connective tissue growth factor regulates cardiac function and tissue remodeling in a mouse model of dilated cardiomyopathy","volume":"89","author":"Koshman","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0090","doi-asserted-by":"crossref","first-page":"9519","DOI":"10.1002\/jcb.27268","article-title":"Silencing CTGF\/CCN2 inactivates the MAPK signaling pathway to alleviate myocardial fibrosis and left ventricular hypertrophy in rats with dilated cardiomyopathy","volume":"119","author":"Hong","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0091","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-4-4","article-title":"Cooperative interaction of CTGF and TGF-\u03b2 in animal models of fibrotic disease","volume":"4","author":"Wang","year":"2011","journal-title":"Fibrogen. Tissue Rep."},{"key":"10.1016\/j.matbio.2024.08.008_bib0092","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.yjmcc.2015.09.015","article-title":"CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload","volume":"88","author":"Fontes","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0093","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1128\/MCB.00199-15","article-title":"Genetic analysis of connective tissue growth factor as an effector of transforming growth factor \u03b2 signaling and cardiac remodeling","volume":"35","author":"Accornero","year":"2015","journal-title":"Mol. Cell. Biol."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0094","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.3390\/ijms22115828","article-title":"Tenascin-C in heart diseases\u2014the role of inflammation","volume":"22","author":"Imanaka-Yoshida","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0095","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/ehf2.12341","article-title":"Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity","volume":"5","author":"Van Linthout","year":"2018","journal-title":"ESC Heart. Fail."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0096","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9440(10)62954-9","article-title":"Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury","volume":"167","author":"Tamaoki","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.matbio.2024.08.008_bib0097","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/HYPERTENSIONAHA.115.06004","article-title":"Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin \u03b1V\u03b23\/nuclear factor\u2013\u03baB\/interleukin-6 axis","volume":"66","author":"Shimojo","year":"2015","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.matbio.2024.08.008_bib0098","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/HJH.0000000000001628","article-title":"Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis","volume":"36","author":"Podesser","year":"2018","journal-title":"J. Hypertens."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0099","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1161\/CIRCRESAHA.107.160408","article-title":"Osteopontin expression is required for myofibroblast differentiation","volume":"102","author":"Lenga","year":"2008","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121558","article-title":"Osteopontin: a promising therapeutic target in cardiac fibrosis","volume":"8","author":"Abdelaziz Mohamed","year":"2019","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0101","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/cvr\/cvx016","article-title":"Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure","volume":"113","author":"Li","year":"2017","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0102","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/01.HYP.0000128621.68160.dd","article-title":"Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy","volume":"43","author":"Matsui","year":"2004","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0103","doi-asserted-by":"crossref","first-page":"H673","DOI":"10.1152\/ajpheart.00569.2006","article-title":"Lack of osteopontin improves cardiac function in streptozotocin-induced diabetic mice","volume":"292","author":"Subramanian","year":"2007","journal-title":"Am. J. Physiol.-Heart Circul. Physiol."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0104","doi-asserted-by":"crossref","first-page":"19757","DOI":"10.1038\/s41598-021-99032-2","article-title":"The extracellular matrix glycoprotein ADAMTSL2 is increased in heart failure and inhibits TGFbeta signalling in cardiac fibroblasts","volume":"11","author":"Rypdal","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0105","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/s41588-023-01371-5","article-title":"Genetics of myocardial interstitial fibrosis in the human heart and association with disease","volume":"55","author":"Nauffal","year":"2023","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0106","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11033-024-09255-5","article-title":"Emerging roles for the ADAMTS-like family of matricellular proteins in cardiovascular disease through regulation of the extracellular microenvironment","volume":"51","author":"Rypdal","year":"2024","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0107","article-title":"ADAMTSL2 mutations determine the phenotypic severity in geleophysic dysplasia","volume":"9","author":"Camarena","year":"2024","journal-title":"JCI Insight."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0108","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s42003-022-04361-1","article-title":"ADAMTSL3 knock-out mice develop cardiac dysfunction and dilatation with increased TGF\u03b2 signalling after pressure overload","volume":"5","author":"Rypdal","year":"2022","journal-title":"Commun. Biol."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0109","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/01.RES.73.3.413","article-title":"Molecular characterization of angiotensin II\u2013induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype","volume":"73","author":"Sadoshima","year":"1993","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0110","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1006\/jmcc.1997.0435","article-title":"Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts","volume":"29","author":"Campbell","year":"1997","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0111","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1006\/jmcc.2000.1129","article-title":"Induction of cardiac fibrosis by aldosterone","volume":"32","author":"Lijnen","year":"2000","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0112","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1358\/mf.2000.22.10.802287","article-title":"Induction of cardiac fibrosis by angiotensin II","volume":"22","author":"Lijnen","year":"2000","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0113","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/ki.1997.185","article-title":"Biology of TGF-beta in knockout and transgenic mouse models","volume":"51","author":"B\u00f6ttinger","year":"1997","journal-title":"Kidney Int."},{"issue":"22","key":"10.1016\/j.matbio.2024.08.008_bib0114","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1161\/01.CIR.103.22.2745","article-title":"Double-outlet right ventricle and overriding tricuspid valve reflect disturbances of looping, myocardialization, endocardial cushion differentiation, and apoptosis in TGF-beta(2)-knockout mice","volume":"103","author":"Bartram","year":"2001","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0115","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/j.1460-2075.1991.tb08049.x","article-title":"A role of the latent TGF-beta 1-binding protein in the assembly and secretion of TGF-beta 1","volume":"10","author":"Miyazono","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.matbio.2024.08.008_bib0116","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","article-title":"The extracellular matrix and transforming growth factor-beta1: tale of a strained relationship","volume":"47","author":"Hinz","year":"2015","journal-title":"Matrix. Biol."},{"issue":"Pt 2","key":"10.1016\/j.matbio.2024.08.008_bib0117","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1242\/jcs.00229","article-title":"Making sense of latent TGFbeta activation","volume":"116","author":"Annes","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.matbio.2024.08.008_bib0118","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.matbio.2015.05.002","article-title":"The fibrillin microfibril scaffold: a niche for growth factors and mechanosensation?","volume":"47","author":"Sengle","year":"2015","journal-title":"Matrix. Biol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0119","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41569-022-00799-2","article-title":"Cardiac fibroblasts and mechanosensation in heart development, health and disease","volume":"20","author":"Pesce","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0120","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/cvr\/cvz187","article-title":"ADAMTS16 activates latent TGF-\u03b2, accentuating fibrosis and dysfunction of the pressure-overloaded heart","volume":"116","author":"Yao","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0121","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1172\/JCI94753","article-title":"Fibroblast-specific TGF-beta-Smad2\/3 signaling underlies cardiac fibrosis","volume":"127","author":"Khalil","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"6659","key":"10.1016\/j.matbio.2024.08.008_bib0122","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-beta signalling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0123","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-4889(91)90066-7","article-title":"The effect of transforming growth factor beta on rates of procollagen synthesis and degradation in vitro","volume":"1091","author":"McAnulty","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0124","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0741-5214(97)70254-4","article-title":"Transforming growth factor-beta 1 increases lysyl oxidase enzyme activity and mRNA in rat aortic smooth muscle cells","volume":"25","author":"Shanley","year":"1997","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.matbio.2024.08.008_bib0125","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.matbio.2018.03.017","article-title":"The WNT signaling pathways in wound healing and fibrosis","volume":"68-69","author":"Burgy","year":"2018","journal-title":"Matrix. Biol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0126","first-page":"59","article-title":"Signaling in fibrosis: TGF-\u03b2, WNT, and YAP\/TAZ converge","volume":"2","author":"Piersma","year":"2015","journal-title":"Front. Med. (Lausanne)"},{"issue":"50","key":"10.1016\/j.matbio.2024.08.008_bib0127","doi-asserted-by":"crossref","first-page":"20785","DOI":"10.1074\/jbc.M117.814376","article-title":"The allosteric glycogen synthase kinase-3 inhibitor NP12 limits myocardial remodeling and promotes angiogenesis in an acute myocardial infarction model","volume":"292","author":"Baruah","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0128","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41467-017-00840-w","article-title":"Loss of \u03b2-catenin in resident cardiac fibroblasts attenuates fibrosis induced by pressure overload in mice","volume":"8","author":"Xiang","year":"2017","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0129","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes Dev."},{"issue":"524","key":"10.1016\/j.matbio.2024.08.008_bib0130","doi-asserted-by":"crossref","first-page":"eaay2140","DOI":"10.1126\/scitranslmed.aay2140","article-title":"Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction","volume":"12","author":"Thavapalachandran","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0131","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jacbts.2022.11.006","article-title":"PDGF-AB reduces myofibroblast differentiation without increasing proliferation after myocardial infarction","volume":"8","author":"Hume","year":"2023","journal-title":"JACC Basic Transl. Sci."},{"key":"10.1016\/j.matbio.2024.08.008_bib0132","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.669188","article-title":"Role of PDGF-A\/B ligands in cardiac repair after myocardial infarction","volume":"9","author":"Kalra","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0133","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1059179","article-title":"Direct and indirect effects of fibroblast growth factor 23 on the heart","volume":"14","author":"Nakano","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0134","doi-asserted-by":"crossref","first-page":"66","DOI":"10.7150\/ijbs.73936","article-title":"Targeting FGF21 in cardiovascular and metabolic diseases: from mechanism to medicine","volume":"19","author":"Tan","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"40","key":"10.1016\/j.matbio.2024.08.008_bib0135","doi-asserted-by":"crossref","first-page":"64649","DOI":"10.18632\/oncotarget.11623","article-title":"FGF23 promotes myocardial fibrosis in mice through activation of \u03b2-catenin","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget."},{"issue":"22","key":"10.1016\/j.matbio.2024.08.008_bib0136","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212341","article-title":"Exercise training alleviates cardiac fibrosis through increasing fibroblast growth factor 21 and regulating TGF-\u03b21-Smad2\/3-MMP2\/9 signaling in mice with myocardial infarction","volume":"22","author":"Ma","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.matbio.2024.08.008_bib0137","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.matbio.2020.04.006","article-title":"Extracellular matrix-derived peptides in tissue remodeling and fibrosis","volume":"91-92","author":"de Castro Br\u00e1s","year":"2020","journal-title":"Matrix. Biol."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0138","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40119-018-0104-3","article-title":"A review of interleukin-1 in heart disease: where do we stand today?","volume":"7","author":"Szekely","year":"2018","journal-title":"Cardiol. Ther."},{"key":"10.1016\/j.matbio.2024.08.008_bib0139","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111858","article-title":"Interleukin-1\u03b2 polarization in M1 macrophage mediates myocardial fibrosis in diabetes","volume":"131","author":"Guo","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0140","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","article-title":"Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats","volume":"56","author":"Mel\u00e9ndez","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.matbio.2024.08.008_bib0141","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947267","article-title":"Left ventricle- and skeletal muscle-derived fibroblasts exhibit a differential inflammatory and metabolic responsiveness to interleukin-6","volume":"13","author":"Matz","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0142","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0143","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1161\/CIRCRESAHA.111.262477","article-title":"Identification and predictive value of interleukin-6+ interleukin-10+ and interleukin-6- interleukin-10+ cytokine patterns in ST-elevation acute myocardial infarction","volume":"111","author":"Ammirati","year":"2012","journal-title":"Circ. Res."},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0144","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102044","article-title":"NIL10: a new IL10-receptor binding nanoparticle that induces cardiac protection in mice and pigs subjected to acute myocardial infarction through STAT3\/NF-\u03baB activation","volume":"14","author":"Tesoro","year":"2022","journal-title":"Pharmaceutics."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0145","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1097\/MS9.0000000000002044","article-title":"IL-4 attenuates myocardial infarction injury by promoting M2 macrophage polarization","volume":"86","author":"Lu","year":"2024","journal-title":"Ann. Med. Surg. (Lond)"},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0146","doi-asserted-by":"crossref","first-page":"H877","DOI":"10.1152\/ajpheart.00223.2019","article-title":"Inflammation in nonischemic heart disease: initiation by cardiomyocyte CaMKII and NLRP3 inflammasome signaling","volume":"317","author":"Suetomi","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0147","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cophys.2020.10.004","article-title":"Chemokines in cardiac fibrosis","volume":"19","author":"Li","year":"2021","journal-title":"Curr. Opin. Physiol."},{"issue":"23","key":"10.1016\/j.matbio.2024.08.008_bib0148","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239232","article-title":"Galectin-3 in cardiovascular diseases","volume":"21","author":"Blanda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0149","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.208884","article-title":"Galectins at a glance","volume":"131","author":"Johannes","year":"2018","journal-title":"J. Cell Sci."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0150","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003381","article-title":"Dual endothelin-A\/endothelin-B receptor blockade and cardiac remodeling in heart failure with preserved ejection fraction","volume":"9","author":"Valero-Munoz","year":"2016","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0151","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/cvr\/cvq351","article-title":"Electrical remodelling precedes heart failure in an endothelin-1-induced model of cardiomyopathy","volume":"89","author":"Mueller","year":"2011","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0152","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030824","article-title":"Endothelin receptor antagonists: status quo and future perspectives for targeted therapy","volume":"9","author":"Enevoldsen","year":"2020","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0153","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/CIRCRESAHA.120.316958","article-title":"Myofibroblasts and fibrosis: mitochondrial and metabolic control of cellular differentiation","volume":"127","author":"Gibb","year":"2020","journal-title":"Circ. Res."},{"issue":"8","key":"10.1016\/j.matbio.2024.08.008_bib0154","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/CIRCRESAHA.111.255216","article-title":"Redox signaling in cardiac physiology and pathology","volume":"111","author":"Burgoyne","year":"2012","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.matbio.2024.08.008_bib0155","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ejhf.1320","article-title":"Treating oxidative stress in heart failure: past, present and future","volume":"21","author":"van der Pol","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.matbio.2024.08.008_bib0156","article-title":"The role of oxidative stress in cardiac disease: from physiological response to injury factor","volume":"2020","author":"D'Oria","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.matbio.2024.08.008_bib0157","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.907757","article-title":"Signaling pathways related to oxidative stress in diabetic cardiomyopathy","volume":"13","author":"Peng","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0158","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/CIRCRESAHA.109.198366","article-title":"Monoamine oxidase A-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload","volume":"106","author":"Kaludercic","year":"2010","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0355-7","article-title":"Mitochondrial dysfunction and oxidative stress in heart disease","volume":"51","author":"Peoples","year":"2019","journal-title":"Exp. Mol. Med."},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0160","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCRESAHA.110.232306","article-title":"Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and Galphaq overexpression-induced heart failure","volume":"108","author":"Dai","year":"2011","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0161","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1074\/jbc.M112.431973","article-title":"Mitochondrial reactive oxygen species regulate transforming growth factor-\u03b2 signaling","volume":"288","author":"Jain","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.matbio.2024.08.008_bib0162","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102820","article-title":"Crosstalk between oxidative stress and epigenetic marks: new roles and therapeutic implications in cardiac fibrosis","volume":"65","author":"Liu","year":"2023","journal-title":"Redox. Biol."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0163","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.bbamcr.2019.06.001","article-title":"The complex dynamics of myocardial interstitial fibrosis in heart failure. Focus on collagen cross-linking","volume":"1866","author":"Gonz\u00e1lez","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0164","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1161\/HYPERTENSIONAHA.112.196113","article-title":"Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase","volume":"60","author":"L\u00f3pez","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.matbio.2024.08.008_bib0165","doi-asserted-by":"crossref","first-page":"13710","DOI":"10.1038\/ncomms13710","article-title":"Targeting LOXL2 for cardiac interstitial fibrosis and heart failure treatment","volume":"7","author":"Yang","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0166","doi-asserted-by":"crossref","first-page":"H463","DOI":"10.1152\/ajpheart.00086.2018","article-title":"Inhibitor of lysyl oxidase improves cardiac function and the collagen\/MMP profile in response to volume overload","volume":"315","author":"El Hajj","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"24","key":"10.1016\/j.matbio.2024.08.008_bib0167","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0168","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jacc.2015.07.035","article-title":"A novel collagen matricryptin reduces left ventricular dilation post-myocardial infarction by promoting scar formation and angiogenesis","volume":"66","author":"Lindsey","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.matbio.2024.08.008_bib0169","first-page":"2583","article-title":"Matrix metalloproteases as a pharmacological target in cardiovascular diseases","volume":"19","author":"Hopps","year":"2015","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3-4","key":"10.1016\/j.matbio.2024.08.008_bib0170","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00508-019-01592-x","article-title":"Plasma MMP-9 and TIMP-1 levels on ICU admission are associated with 30-day survival","volume":"133","author":"Jordakieva","year":"2021","journal-title":"Wien. Klin. Wochenschr."},{"key":"10.1016\/j.matbio.2024.08.008_bib0171","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.matbio.2018.06.002","article-title":"ADAMTS proteins in human disorders","volume":"71-72","author":"Mead","year":"2018","journal-title":"Matrix. Biol."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0172","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.200333","article-title":"ADAMTS proteases in cardiovascular physiology and disease","volume":"10","author":"Santamaria","year":"2020","journal-title":"Open. Biol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0173","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2021.104358","article-title":"Identification of novel ADAMTS1, ADAMTS4 and ADAMTS5 cleavage sites in versican using a label-free quantitative proteomics approach","volume":"249","author":"Martin","year":"2021","journal-title":"J. Proteomics"},{"issue":"4","key":"10.1016\/j.matbio.2024.08.008_bib0174","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.matbio.2010.01.005","article-title":"Reduced versican cleavage due to Adamts9 haploinsufficiency is associated with cardiac and aortic anomalies","volume":"29","author":"Kern","year":"2010","journal-title":"Matrix. Biol."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0175","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1161\/HYPERTENSIONAHA.116.08581","article-title":"Critical role of ADAMTS2 (A disintegrin and metalloproteinase with thrombospondin motifs 2) in cardiac hypertrophy induced by pressure overload","volume":"69","author":"Wang","year":"2017","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0176","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1038\/s41598-017-12248-z","article-title":"Critical role of ADAMTS-4 in the development of sporadic aortic aneurysm and dissection in mice","volume":"7","author":"Ren","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.matbio.2024.08.008_bib0177","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.matbio.2018.01.024","article-title":"Cysteine cathepsins in extracellular matrix remodeling: extracellular matrix degradation and beyond","volume":"75-76","author":"Vizovi\u0161ek","year":"2019","journal-title":"Matrix. Biol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0178","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yjmcc.2018.11.010","article-title":"Cathepsin K-deficiency impairs mouse cardiac function after myocardial infarction","volume":"127","author":"Fang","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0179","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ejhf.2190","article-title":"Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"36","key":"10.1016\/j.matbio.2024.08.008_bib0180","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0181","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ejhf.2201","volume":"23","author":"Raafs","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0182","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"L\u00f3pez","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0183","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.CIR.104.3.286","article-title":"Usefulness of serum carboxy-terminal propeptide of procollagen type I in assessment of the cardioreparative ability of antihypertensive treatment in hypertensive patients","volume":"104","author":"L\u00f3pez","year":"2001","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.matbio.2024.08.008_bib0184","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/eurheartj\/ehx353","article-title":"Reappraising myocardial fibrosis in severe aortic stenosis: an invasive and non-invasive study in 133 patients","volume":"39","author":"Treibel","year":"2018","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0185","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCULATIONAHA.111.025270","article-title":"Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness","volume":"124","author":"Falc\u00e3o-Pires","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0186","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jchf.2020.04.007","article-title":"Endomyocardial biopsy characterization of heart failure with preserved ejection fraction and prevalence of cardiac amyloidosis","volume":"8","author":"Hahn","year":"2020","journal-title":"JACC Heart. Fail."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0187","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1161\/01.CIR.102.12.1388","article-title":"Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease","volume":"102","author":"Brilla","year":"2000","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.matbio.2024.08.008_bib0188","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1136\/heartjnl-2019-315560","article-title":"Myocardial fibrosis: why image, how to image and clinical implications","volume":"105","author":"Bing","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.matbio.2024.08.008_bib0189","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101194","article-title":"Cardiac fibrosis in heart failure: focus on non-invasive diagnosis and emerging therapeutic strategies","volume":"93","author":"Ravassa","year":"2023","journal-title":"Mol. Aspects Med."},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0190","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/01.CIR.0000138930.12773.41","article-title":"Severe aortic stenosis and myocardial function: diagnostic and prognostic usefulness of ultrasonic integrated backscatter analysis","volume":"110","author":"Di Bello","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0191","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s10741-020-10058-6","article-title":"Fibrosis in hypertrophic cardiomyopathy: role of novel echo techniques and multi-modality imaging assessment","volume":"26","author":"Pagourelias","year":"2021","journal-title":"Heart Fail. Rev."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0192","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s10741-022-10214-0","article-title":"Detection of myocardial fibrosis by speckle-tracking echocardiography: from prediction to clinical applications","volume":"27","author":"Lisi","year":"2022","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0193","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1532-429X-14-54","article-title":"Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies","volume":"14","author":"Parsai","year":"2012","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0194","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11886-018-0961-3","article-title":"Myocardial extracellular volume quantification by cardiovascular magnetic resonance and computed tomography","volume":"20","author":"Scully","year":"2018","journal-title":"Curr. Cardiol. Rep."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"Messroghli","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0196","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamacardio.2022.0340","article-title":"Association of myocardial fibrosis and stroke volume by cardiovascular magnetic resonance in patients with severe aortic stenosis with outcome after valve replacement: the British Society of cardiovascular magnetic resonance AS700 study","volume":"7","author":"Thornton","year":"2022","journal-title":"JAMA Cardiol."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0197","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0198","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jcmg.2021.10.016","article-title":"Myocardial fibrosis quantified by cardiac CT predicts outcome in severe aortic stenosis after transcatheter intervention","volume":"15","author":"Scully","year":"2022","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0199","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/ehjci\/jeac242","article-title":"Emerging molecular imaging targets and tools for myocardial fibrosis detection","volume":"24","author":"Barton","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1874471007666140902152916","article-title":"Isomers of 4-[18F]fluoro-proline: radiosynthesis, biological evaluation and results in humans using PET","volume":"7","author":"Geisler","year":"2014","journal-title":"Curr. Radiopharm."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0201","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.120.010628","article-title":"Relationship between cardiac fibroblast activation protein activity by positron emission tomography and cardiovascular disease","volume":"13","author":"Heckmann","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0202","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005897","article-title":"Proteomic bioprofiles and mechanistic pathways of progression to heart failure","volume":"12","author":"Ferreira","year":"2019","journal-title":"Circ. Heart Fail."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0203","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1002\/ejhf.2195","article-title":"Urinary peptides in heart failure: a link to molecular pathophysiology","volume":"23","author":"He","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0204","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.CIR.0000140973.60992.9A","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jhh.2008.98","article-title":"Time course of serum collagen types I and III metabolism products after reperfused acute myocardial infarction in patients with and without systemic hypertension","volume":"23","author":"Cerisano","year":"2009","journal-title":"J. Hum. Hypertens."},{"key":"10.1016\/j.matbio.2024.08.008_bib0206","doi-asserted-by":"crossref","DOI":"10.1016\/j.carpath.2019.107150","article-title":"Procollagen type I carboxy-terminal propeptide (PICP) and MMP-2 are potential biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy","volume":"43","author":"Yang","year":"2019","journal-title":"Cardiovasc. Pathol."},{"issue":"21","key":"10.1016\/j.matbio.2024.08.008_bib0207","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1161\/01.CIR.0000017264.66561.3D","article-title":"Losartan-dependent regression of myocardial fibrosis is associated with reduction of left ventricular chamber stiffness in hypertensive patients","volume":"105","author":"D\u00edez","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0208","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/eurheartj\/ehaa758","article-title":"The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial","volume":"42","author":"Cleland","year":"2021","journal-title":"Eur. Heart J."},{"issue":"19","key":"10.1016\/j.matbio.2024.08.008_bib0209","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1161\/CIRCULATIONAHA.105.571653","article-title":"Mineralocorticoid receptor antagonism ameliorates left ventricular diastolic dysfunction and myocardial fibrosis in mildly symptomatic patients with idiopathic dilated cardiomyopathy: a pilot study","volume":"112","author":"Izawa","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0210","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/ejhf.3101","article-title":"Effects of empagliflozin on collagen biomarkers in patients with heart failure: findings from the EMPEROR trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0211","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jchf.2022.09.008","article-title":"Prediction of left ventricular reverse remodeling and outcomes by circulating collagen-derived peptides","volume":"11","author":"Ravassa","year":"2023","journal-title":"JACC Heart. Fail."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0212","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jacc.2015.10.063","article-title":"Myocardial collagen cross-linking is associated with heart failure hospitalization in patients with hypertensive heart failure","volume":"67","author":"L\u00f3pez","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0213","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/ejhf.1194","article-title":"Biomarker-based phenotyping of myocardial fibrosis identifies patients with heart failure with preserved ejection fraction resistant to the beneficial effects of spironolactone: results from the Aldo-DHF trial","volume":"20","author":"Ravassa","year":"2018","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.matbio.2024.08.008_bib0214","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/HJH.0000000000001258","article-title":"Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome","volume":"35","author":"Ravassa","year":"2017","journal-title":"J. Hypertens."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0215","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.jacc.2018.12.074","article-title":"Combination of circulating type i collagen-related biomarkers is associated with atrial fibrillation","volume":"73","author":"Ravassa","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.matbio.2024.08.008_bib0216","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0002-9149(99)80686-9","article-title":"Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis","volume":"75","author":"Klappacher","year":"1995","journal-title":"Am. J. Cardiol."},{"issue":"18","key":"10.1016\/j.matbio.2024.08.008_bib0217","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.matbio.2024.08.008_bib0218","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0219","article-title":"Endotrophin, a collagen VI formation-derived peptide","volume":"1","author":"Chirinos","year":"2022","journal-title":"Heart Fail. NEJM Evid."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0220","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ejhf.2493","article-title":"Cardiac remodelling \u2013 Part 1: from cells and tissues to circulating biomarkers. A review from the study group on biomarkers of the Heart Failure Association of the European Society of Cardiology","volume":"24","author":"Gonz\u00e1lez","year":"2022","journal-title":"Eur. J. Heart Fail."},{"issue":"17","key":"10.1016\/j.matbio.2024.08.008_bib0221","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.jacc.2019.08.1039","article-title":"Clinical and prognostic significance of sST2 in heart failure: JACC review topic of the week","volume":"74","author":"Aimo","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0222","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","article-title":"Effects of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF","volume":"73","author":"Zile","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0223","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jacc.2020.05.072","article-title":"Effect of sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFpEF","volume":"76","author":"Cunningham","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.matbio.2024.08.008_bib0224","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.cardfail.2011.04.007","article-title":"Results of the randomized aldosterone antagonism in heart failure with preserved ejection fraction trial (RAAM-PEF)","volume":"17","author":"Deswal","year":"2011","journal-title":"J. Card. Fail."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0225","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011521","article-title":"Myocardial effects of aldosterone antagonism in heart failure with preserved ejection fraction","volume":"9","author":"McDiarmid","year":"2020","journal-title":"J. Am. Heart. Assoc."},{"key":"10.1016\/j.matbio.2024.08.008_bib0226","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.addr.2021.03.021","article-title":"Cardiac fibrosis: myofibroblast-mediated pathological regulation and drug delivery strategies","volume":"173","author":"Liu","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0227","doi-asserted-by":"crossref","first-page":"6309","DOI":"10.1021\/acsbiomaterials.0c00942","article-title":"Cardiac stromal cell patch integrated with engineered microvessels improves recovery from myocardial infarction in rats and pigs","volume":"6","author":"Su","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0228","doi-asserted-by":"crossref","first-page":"eaat9365","DOI":"10.1126\/sciadv.aat9365","article-title":"Cardiac cell-integrated microneedle patch for treating myocardial infarction","volume":"4","author":"Tang","year":"2018","journal-title":"Sci. Adv."},{"key":"10.1016\/j.matbio.2024.08.008_bib0229","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120356","article-title":"Engineered cell-degradable poly(2-alkyl-2-oxazoline) hydrogel for epicardial placement of mesenchymal stem cells for myocardial repair","volume":"269","author":"You","year":"2021","journal-title":"Biomaterials"},{"issue":"19","key":"10.1016\/j.matbio.2024.08.008_bib0230","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202300029","article-title":"Advances in injectable hydrogel strategies for heart failure treatment","volume":"12","author":"He","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.matbio.2024.08.008_bib0231","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41551-017-0182-x","article-title":"Targeted repair of heart injury by stem cells fused with platelet nanovesicles","volume":"2","author":"Tang","year":"2018","journal-title":"Nat. Biomed. Eng."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0232","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1021\/acs.nanolett.8b04970","article-title":"Antibody-armed platelets for the regenerative targeting of endogenous stem cells","volume":"19","author":"Shen","year":"2019","journal-title":"Nano Lett."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0233","article-title":"Bispecific antibody inhalation therapy for redirecting stem cells from the lungs to repair heart injury","volume":"8","author":"Liu","year":"2020","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.matbio.2024.08.008_bib0234","doi-asserted-by":"crossref","first-page":"8099","DOI":"10.2147\/IJN.S443716","article-title":"A powerful tool in the treatment of myocardial ischemia-reperfusion injury: natural and nanoscale modified small extracellular vesicles derived from mesenchymal stem cells","volume":"18","author":"Zhou","year":"2023","journal-title":"Int. J. Nanomed."},{"issue":"6610","key":"10.1016\/j.matbio.2024.08.008_bib0235","doi-asserted-by":"crossref","first-page":"eabm4443","DOI":"10.1126\/science.abm4443","article-title":"A coalition to heal-the impact of the cardiac microenvironment","volume":"377","author":"Tzahor","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.matbio.2024.08.008_bib0236","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2018.03.042","article-title":"Injectable hyaluronic acid based microrods provide local micromechanical and biochemical cues to attenuate cardiac fibrosis after myocardial infarction","volume":"169","author":"Le","year":"2018","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0237","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1038\/s41467-019-12748-8","article-title":"Injectable human recombinant collagen matrices limit adverse remodeling and improve cardiac function after myocardial infarction","volume":"10","author":"McLaughlin","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0238","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1038\/s41598-020-66327-9","article-title":"Acellular bioscaffolds redirect cardiac fibroblasts and promote functional tissue repair in rodents and humans with myocardial injury","volume":"10","author":"Svystonyuk","year":"2020","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0239","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900544","article-title":"Development of injectable amniotic membrane matrix for postmyocardial infarction tissue repair","volume":"9","author":"Henry","year":"2020","journal-title":"Adv. Healthc. Mater."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0240","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jacbts.2019.07.012","article-title":"First-in-man study of a cardiac extracellular matrix hydrogel in early and late myocardial infarction patients","volume":"4","author":"Traverse","year":"2019","journal-title":"JACC Basic Transl. Sci."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0241","doi-asserted-by":"crossref","first-page":"H424","DOI":"10.1152\/ajpheart.00529.2009","article-title":"Inhibition of transforming growth factor-beta signaling induces left ventricular dilation and dysfunction in the pressure-overloaded heart","volume":"298","author":"Lucas","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0242","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00395-008-0739-7","article-title":"Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction","volume":"103","author":"Frantz","year":"2008","journal-title":"Basic Res. Cardiol."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0243","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.cardiores.2004.07.017","article-title":"Inhibition of TGF-beta signaling exacerbates early cardiac dysfunction but prevents late remodeling after infarction","volume":"64","author":"Ikeuchi","year":"2004","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0244","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","article-title":"Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats","volume":"106","author":"Kuwahara","year":"2002","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.matbio.2024.08.008_bib0245","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1161\/01.CIR.0000165066.71481.8E","article-title":"Postinfarction gene therapy against transforming growth factor-beta signal modulates infarct tissue dynamics and attenuates left ventricular remodeling and heart failure","volume":"111","author":"Okada","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0246","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/cvr\/cvx026","article-title":"Transforming growth factor \u03b2 receptor inhibition prevents ventricular fibrosis in a mouse model of progressive cardiac conduction disease","volume":"113","author":"Derangeon","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.matbio.2024.08.008_bib0247","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.yjmcc.2014.08.008","article-title":"Attenuated development of cardiac fibrosis in left ventricular pressure overload by SM16, an orally active inhibitor of ALK5","volume":"76","author":"Engebretsen","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"18","key":"10.1016\/j.matbio.2024.08.008_bib0248","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2019.02.049","article-title":"Myofibroblast phenotype and reversibility of fibrosis in patients with end-stage heart failure","volume":"73","author":"Nagaraju","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0249","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/ph17030267","article-title":"Hitting the target! challenges and opportunities for TGF-\u03b2 inhibition for the treatment of cardiac fibrosis","volume":"17","author":"Vistnes","year":"2024","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/toxsci\/kfaa024","article-title":"A potent pan-TGF\u03b2 neutralizing monoclonal antibody elicits cardiovascular toxicity in mice and cynomolgus monkeys","volume":"175","author":"Mitra","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.matbio.2024.08.008_bib0251","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0252","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvu062","article-title":"Crosstalk between fibroblasts and inflammatory cells","volume":"102","author":"Van Linthout","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0253","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/cvr\/cvaa137","article-title":"Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function","volume":"116","author":"Steffens","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0254","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/cpt.1637","article-title":"The quest for antiinflammatory and immunomodulatory strategies in heart failure","volume":"106","author":"Van Linthout","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41569-023-00919-6","article-title":"Immunomodulation and immunopharmacology in heart failure","volume":"21","author":"Markousis-Mavrogenis","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0256","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20071599","article-title":"NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases","volume":"20","author":"Fiordelisi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0257","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/01.RES.0000130526.20854.fa","article-title":"Inflammatory cytokines and postmyocardial infarction remodeling","volume":"94","author":"Nian","year":"2004","journal-title":"Circ. Res."},{"issue":"25","key":"10.1016\/j.matbio.2024.08.008_bib0258","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1161\/01.CIR.0000108929.93074.0B","article-title":"Nuclear factor-\u03baB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction","volume":"108","author":"Misra","year":"2003","journal-title":"Circulation"},{"issue":"29","key":"10.1016\/j.matbio.2024.08.008_bib0259","doi-asserted-by":"crossref","first-page":"11794","DOI":"10.1073\/pnas.1116584109","article-title":"Cardiomyocyte-specific I\u03baB kinase (IKK)\/NF-\u03baB activation induces reversible inflammatory cardiomyopathy and heart failure","volume":"109","author":"Maier","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0260","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/jcp.24296","article-title":"NF-\u03baB mediated miR-26a regulation in cardiac fibrosis","volume":"228","author":"Wei","year":"2013","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0261","article-title":"The role of the NLRP3 inflammasome and pyroptosis in cardiovascular diseases","author":"Toldo","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0262","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ehf2.13845","article-title":"Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis","volume":"9","author":"Pappritz","year":"2022","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.matbio.2024.08.008_bib0263","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113573","article-title":"Colchicine: emerging therapeutic effects on atrial fibrillation by alleviating myocardial fibrosis in a rat model","volume":"154","author":"Yue","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0264","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/db06-1662","article-title":"Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy","volume":"56","author":"Westermann","year":"2007","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0265","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00395-014-0449-2","article-title":"Interleukin-6 receptor inhibition modulates the immune reaction and restores titin phosphorylation in experimental myocarditis","volume":"109","author":"Savvatis","year":"2014","journal-title":"Basic Res. Cardiol."},{"issue":"7","key":"10.1016\/j.matbio.2024.08.008_bib0266","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1161\/ATVBAHA.120.314370","article-title":"Lymphatic and immune cell cross-talk regulates cardiac recovery after experimental myocardial infarction","volume":"40","author":"Houssari","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0267","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/cvr\/cvac086","article-title":"Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure","volume":"119","author":"Heron","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"6","key":"10.1016\/j.matbio.2024.08.008_bib0268","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jacc.2020.05.076","article-title":"Role of cardiac lymphatics in myocardial edema and fibrosis: JACC review topic of the week","volume":"76","author":"Brakenhielm","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0269","doi-asserted-by":"crossref","DOI":"10.1172\/JCI140685","article-title":"Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation","volume":"132","author":"Glinton","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2024.08.008_bib0270","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201701408R","article-title":"Immunomodulation by adoptive regulatory T-cell transfer improves coxsackievirus B3-induced myocarditis","author":"Pappritz","year":"2018","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0271","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.12.004","article-title":"Efferocytosis fuels requirements of fatty acid oxidation and the electron transport chain to polarize macrophages for tissue repair","volume":"29","author":"Zhang","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.matbio.2024.08.008_bib0272","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.yjmcc.2019.08.002","article-title":"Metabolic reprogramming orchestrates CD4(+) T-cell immunological status and restores cardiac dysfunction in autoimmune induced-dilated cardiomyopathy mice","volume":"135","author":"Wu","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7742","key":"10.1016\/j.matbio.2024.08.008_bib0273","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41586-018-0849-9","article-title":"Gut intraepithelial T cells calibrate metabolism and accelerate cardiovascular disease","volume":"566","author":"He","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.matbio.2024.08.008_bib0274","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","author":"Ussher","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.matbio.2024.08.008_bib0275","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes. Endocrinol."},{"key":"10.1016\/j.matbio.2024.08.008_bib0276","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.720690","article-title":"Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction-a specific HFpEF phenotype","volume":"8","author":"Elsanhoury","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"issue":"12","key":"10.1016\/j.matbio.2024.08.008_bib0277","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0278","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003201","article-title":"Elevated plasma GLP-1 levels and enhanced expression of cardiac GLP-1 receptors as markers of left ventricular systolic dysfunction: a cross-sectional study","volume":"3","author":"Hattori","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.matbio.2024.08.008_bib0279","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic. Biol. Med."},{"issue":"7774","key":"10.1016\/j.matbio.2024.08.008_bib0280","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"issue":"6576","key":"10.1016\/j.matbio.2024.08.008_bib0281","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0282","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"issue":"7400","key":"10.1016\/j.matbio.2024.08.008_bib0283","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"issue":"6290","key":"10.1016\/j.matbio.2024.08.008_bib0284","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.aaf1502","article-title":"Conversion of human fibroblasts into functional cardiomyocytes by small molecules","volume":"352","author":"Cao","year":"2016","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.matbio.2024.08.008_bib0285","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/CIRCULATIONAHA.121.057879","article-title":"Glutaminolysis is essential for myofibroblast persistence and in vivo targeting reverses fibrosis and cardiac dysfunction in heart failure","volume":"145","author":"Gibb","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0286","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12933-018-0745-5","article-title":"Potential mechanisms responsible for cardioprotective effects of sodium-glucose co-transporter 2 inhibitors","volume":"17","author":"Lahnwong","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"issue":"18","key":"10.1016\/j.matbio.2024.08.008_bib0287","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1093\/cvr\/cvac142","article-title":"Emerging epigenetic therapies of cardiac fibrosis and remodelling in heart failure: from basic mechanisms to early clinical development","volume":"118","author":"McKinsey","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0288","doi-asserted-by":"crossref","DOI":"10.1172\/JCI148554","article-title":"Therapeutic targets for cardiac fibrosis: from old school to next-gen","volume":"132","author":"Travers","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2024.08.008_bib0289","doi-asserted-by":"crossref","DOI":"10.1016\/j.matbio.2024.02.008","article-title":"The role of fibrosis in cardiomyopathies: an opportunity to develop novel biomarkers of disease activity","author":"Angeli","year":"2024","journal-title":"Matrix. Biol."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0290","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/s41569-019-0218-x","article-title":"RNA-based diagnostic and therapeutic strategies for cardiovascular disease","volume":"16","author":"Lu","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"issue":"7224","key":"10.1016\/j.matbio.2024.08.008_bib0291","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.matbio.2024.08.008_bib0292","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/j.jacc.2020.02.041","article-title":"AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia\/reperfusion injury","volume":"75","author":"Hinkel","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.matbio.2024.08.008_bib0293","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1016\/j.jacc.2021.04.028","article-title":"AntimiR-132 attenuates myocardial hypertrophy in an animal model of percutaneous aortic constriction","volume":"77","author":"Hinkel","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.matbio.2024.08.008_bib0294","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehaa791","article-title":"CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure","volume":"42","author":"Batkai","year":"2021","journal-title":"Eur. Heart J."},{"issue":"5","key":"10.1016\/j.matbio.2024.08.008_bib0295","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCRESAHA.117.310624","article-title":"Inhibition of the cardiac fibroblast-enriched lncRNA Meg3 prevents cardiac fibrosis and diastolic dysfunction","volume":"121","author":"Piccoli","year":"2017","journal-title":"Circ. Res."},{"issue":"395","key":"10.1016\/j.matbio.2024.08.008_bib0296","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai9118","article-title":"The long noncoding RNA wisper controls cardiac fibrosis and remodeling","volume":"9","author":"Micheletti","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.matbio.2024.08.008_bib0297","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1161\/CIRCULATIONAHA.122.062601","article-title":"Assessment of the cardiac noncoding transcriptome by single-cell RNA sequencing identifies FIXER, a conserved profibrogenic long noncoding RNA","volume":"148","author":"Aghagolzadeh","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.matbio.2024.08.008_bib0298","first-page":"868","article-title":"The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats","volume":"118","author":"Morimoto","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.matbio.2024.08.008_bib0299","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2840-13-89","article-title":"High glucose induces Smad activation via the transcriptional coregulator p300 and contributes to cardiac fibrosis and hypertrophy","volume":"13","author":"Bugyei-Twum","year":"2014","journal-title":"Cardiovasc. Diabetol."},{"issue":"11","key":"10.1016\/j.matbio.2024.08.008_bib0300","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/15592294.2017.1370173","article-title":"A novel acetyltransferase p300 inhibitor ameliorates hypertension-associated cardio-renal fibrosis","volume":"12","author":"Rai","year":"2017","journal-title":"Epigenetics."},{"issue":"4","key":"10.1016\/j.matbio.2024.08.008_bib0301","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1111\/jcmm.14162","article-title":"Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis","volume":"23","author":"Rai","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"19","key":"10.1016\/j.matbio.2024.08.008_bib0302","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1161\/CIRCULATIONAHA.120.046462","article-title":"HDAC inhibition reverses preexisting diastolic dysfunction and blocks covert extracellular matrix remodeling","volume":"143","author":"Travers","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.matbio.2024.08.008_bib0303","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2013.12.013","article-title":"Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes","volume":"67","author":"Williams","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"1","key":"10.1016\/j.matbio.2024.08.008_bib0304","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCULATIONAHA.105.559724","article-title":"Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding","volume":"113","author":"Kee","year":"2006","journal-title":"Circulation"},{"issue":"7867","key":"10.1016\/j.matbio.2024.08.008_bib0305","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-021-03674-1","article-title":"A transcriptional switch governs fibroblast activation in heart disease","volume":"595","author":"Alexanian","year":"2021","journal-title":"Nature"},{"issue":"390","key":"10.1016\/j.matbio.2024.08.008_bib0306","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5084","article-title":"BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure","volume":"9","author":"Duan","year":"2017","journal-title":"Sci. Transl. Med."}],"container-title":["Matrix Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X24001100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0945053X24001100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T04:21:11Z","timestamp":1778559671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0945053X24001100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":306,"alternative-id":["S0945053X24001100"],"URL":"https:\/\/doi.org\/10.1016\/j.matbio.2024.08.008","relation":{},"ISSN":["0945-053X"],"issn-type":[{"value":"0945-053X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact","name":"articletitle","label":"Article Title"},{"value":"Matrix Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.matbio.2024.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}